Skip to main content
logo
Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.5300
+0.0397 (8.10%)
At close: Apr 7, 2026

Lyra Therapeutics Revenue

In the year 2025, Lyra Therapeutics had annual revenue of $398.00K, down -74.05%. Lyra Therapeutics had revenue of $7.00K in the quarter ending December 31, 2025, a decrease of -96.65%.

Revenue
398.00K
Revenue Growth
-74.05%
P/S Ratio
2.36
Revenue / Employee
13.27K
Employees
30
Market Cap
940.69K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025398.00K-1.14M-74.05%
Dec 31, 20241.53M-24.00K-1.54%
Dec 31, 20231.56M195.00K14.31%
Dec 31, 20221.36M1.08M378.25%
Dec 31, 2021285.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evofem Biosciences20.18M
Emmaus Life Sciences12.45M
SQZ Biotechnologies Company12.12M
Scorpius Holdings1.72M
Avenue Therapeutics1.40M
Eastgate Biotech137.64K
THC Farmaceuticals18.52K
Halberd6.94K
Revenue Rankings

Lyra Therapeutics News

More News